Pacira Pharmaceuticals, Inc. to Present at the Jefferies and Co. 2013 Global Healthcare Conference
5/28/2013 8:29:16 AM
More...
|
Pacira Pharmaceuticals, Inc. to Present at the Bank of America (BAC) Merrill Lynch 2013 Health Care Conference
5/8/2013 8:21:57 AM
More...
|
Pacira Pharmaceuticals, Inc. Reports $10.4 Million in First Quarter EXPAREL Revenue and Full First Quarter 2013 Financial Results
5/8/2013 8:20:48 AM
More...
|
Pacira Pharmaceuticals, Inc. Release: Two New Studies Support Use of EXPAREL Via Infiltration Into the Transversus Abdominis Plane for Postsurgical Pain Control
5/7/2013 11:11:22 AM
More...
|
Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call
5/1/2013 7:30:44 AM
More...
|
Pacira Pharmaceuticals, Inc. Release: New Data Support the Benefits of EXPAREL for Postsurgical Analgesia Following Aesthetic Plastic Surgery Procedures
4/12/2013 11:31:42 AM
More...
|
Pacira Pharmaceuticals, Inc. to Close the NASDAQ Stock Market on April 8, 2013
4/5/2013 9:57:40 AM
More...
|
Pacira Pharmaceuticals, Inc. Reports 2012 Financial Results
3/7/2013 6:23:50 AM
More...
|
Pacira Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference
3/6/2013 6:31:31 AM
More...
|
Pacira Pharmaceuticals, Inc. Announces Pricing of $110 Million Private Offering of Convertible Senior Notes
1/17/2013 9:29:20 AM
More...
|
|